WHO Model Prescribing Information: Drugs Used in Skin Diseases
(1997; 132 pages) [French] [Spanish] View the PDF document
Table of Contents
View the documentPreface
View the documentIntroduction
Open this folder and view contentsParasitic infections
Open this folder and view contentsInsect and arachnid bites and stings
Open this folder and view contentsSuperficial fungal infections
Open this folder and view contentsSubcutaneous fungal infections
Open this folder and view contentsBacterial infections
Open this folder and view contentsViral infections
Open this folder and view contentsEczematous diseases
Open this folder and view contentsScaling diseases
Open this folder and view contentsPapulosquamous diseases
View the documentCutaneous reactions to drugs
Open this folder and view contentsPigmentary disorders
Open this folder and view contentsPremalignant lesions and malignant tumours
Open this folder and view contentsPhotodermatoses
Open this folder and view contentsBullous dermatoses
View the documentAlopecia areata
View the documentUrticaria
Open this folder and view contentsConditions common in children
View the documentAcne vulgaris
View the documentPruritus
View the documentTropical ulcers
Open this folder and view contentsAntimicrobial drugs
Open this folder and view contentsAntifugal drugs
Open this folder and view contentsAntiseptic agents
Close this folderKeratoplastic and keratolytic agents
View the documentBenzoyl peroxide
View the documentCoal tar
View the documentDithranol
View the documentSalicylic acid
View the documentTretinoin
Open this folder and view contentsScabicides and pediculicides
Open this folder and view contentsAnti-inflammatory and antipruritic drugs1
Open this folder and view contentsAntiallergics and drugs used in anaphylaxis
Open this folder and view contentsUltraviolet radiation-blocking agents (sunscreens)
Open this folder and view contentsMiscellaneous drugs
Open this folder and view contentsAnnex
View the documentSelected WHO Publications of Related Interest
View the documentBack cover
 

Salicylic acid

Ointment or paste, 1-6%

General information

Salicylic acid is a keratolytic agent. It is readily absorbed following topical application and is excreted slowly in the urine.

Clinical information

Uses

Treatment of hyperkeratotic conditions, including corns, ichthyosis, xerosis, psoriasis and pityriasis (tinea) versicolor.

Dosage and administration

All doses are suitable for adults and children over 2 years.

Corns and pityriasis (tinea) versicolor:

Initially a thin layer of the 2% ointment or paste is applied daily. The concentration is progressively increased to a maximum of 6%, and applications are continued until a satisfactory remission is obtained.

Ichthyosis and xerosis:

Treatment is usually started with the 1% ointment or paste applied daily. The concentration is gradually increased to a maximum of 5%, and treatment is continued for as long as lesions persist.

Psoriasis:

A thin layer of the 1% or 2% ointment is applied daily until the lesions have resolved.

Contraindications

Age under 2 years.

Precautions

Salicylic acid should not be applied to broken or inflamed skin.

Adverse effects

Allergic contact dermatitis has rarely been reported.

Treatment of large areas can result in systemic salicylism, particularly in young children.

Storage

Preparations should be stored in well-closed containers.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 1, 2019